הצגת המקור של הדף "טבלאות רגישויות מבית החולים שערי צדק - תרביות שתן - Shaare zedek medical center antibiotic sensitivity table - urine cultures"

{{פנקס|
|שם המחבר=פרופ' עמוס ינון, פרופ' יחיאל שלזינגר, דר' דוד רווה
|שם הפרק={{שם הדף}}
|עורך מדעי=
|מאת=
|אחראי הערך=
}}
==Table 12: Urine cultures  ==
<div class="mw-content-ltr">
===Table 12a: Urine cultures, main isolates, by source of patients (2001-2008)===
</div>{{רווח קשיח}}
{| dir="ltr" border="1" cellpadding="4"
!Isolated organism
!≤48 hours in hospital 
N=21833
!>48 hours in hospital 
N=9823
!p
|-
|	Acinetobacter	||	237 (1)	||	585 (6)	||	<0.001
|-
|	Enterobacteriaceae (total)	||	15323 (70)||5397 (55)	||	<0.001
|-
|	Citrobacter koserii	||	499 (2)	||	174 (2)	||	
|-
|	Enterobacter cloacae	||	411 (2)	||	312 (3)	||	
|-
|	E.coli	||	8853 (40)	||	1927 (20)	||	<0.001
|-
|	Klebsiella pneumoniae	||	2132 (10)	||	1371 (14)	||	<0.001
|-
|	Morganella morganii	||	360 (2)	||	192 (2)	||	
|-	
|	Proteus mirabilis	||	1640 (7)||	762 (8)	||	<0.01
|-
|	Providencia stuartii	||	196	||	131	||	
|-
| Serratia marcescens	||	77	||	52	||	
|-
|Enterococcus sp.	||	2467 (11)||	1833 (19)	||	<0.001
|-
|	Pseudomonas aeruginosa	||	1404 (6)||	1263 (13)	||<0.001
|-
|	Staphylococcus aureus	||	394 (1)	||	107 (1)	||	
|-
|	Staphylococcus epidermidis	||	686 (3)	||	309 (3)	||	
|-
|	Streptococcus	||	707 (3)	||	123 (1)	||	<0.001
|-
| [[Group A Streptococcus|Group A]]	||	22	||	4	||	
|-
|	[[GBS|Group B]]	||	394 (2)	||	50  (0.5)	||	<0.001
|-
| Group D	||	90	||	24	||	
|-
| Group G	||	12	||	3	||	
|-
|	S.viridans	||	122	||	15	||
|}

{{רווח קשיח}}
<div class="mw-content-ltr">

===Table 12b: Antimicrobial susceptibilities (%) of Enterobacteriaceae isolated from urine cultures, 2000-2008===
</div>{{רווח קשיח}}
{| dir="ltr" border="1" cellpadding="4"
!
N
!≤48 hrs in hospital{{כ}}{{הערה|שם=הערה1|Differences in rates of susceptibility between community and hospital acquired strains were significant for all antimicrobials (p<0.001).}} 
15316	
!>48 hours in hospital{{הערה|שם=הערה1}} 
5397
|-
| colspan="3" |[[Penicillins]]
|-
|	[[Augmentin]]	||	65	||	51
|-
|	[[Tazocin]]	||	92	||	82
|-
| colspan="3" |[[Cephalosporins]]
|-
|[[t:Cefazolin|Cefazolin]]||	63	||	43
|-
|	[[Cefuroxime]]	||	76	||	56
|-
| [[Ceftriaxone]]	||	84	||	66
|-
|	[[Ceftazidime]]	||	84	||	67
|-
|	[[Cefepime]]	||	86	||	69
|-
| colspan="3" |[[Carbapenem|Carbapenems]]
|-
|	[[Ertapenem]]	||	99	||	96
|-
|	[[Imipenem]]	||	99	||	98
|-
| colspan="3" |[[Aminoglycosides]]
|-
|	[[Gentamicin]]	||	85	||	69
|-
| [[Amikacin]]	||	98	||	94
|-
| colspan="3" |Other
|-
|	[[Chloramphenicol]]	||	78	||	62
|-
|	[[Cotrimoxazole]]	||	62	||	52
|-
|	[[Ciprofloxacin|Ciprofloxacin{{כ}}]]{{הערה|1=No significant changes in susceptibility % were noted over the study period.}}||	76	||	60
|-
|	[[Colistin]]	||	84	||	77
|-
| [[Nitrofurantoin]]	||	70	||	52
|-
|ESBL (Extended Spectrum Beta-Lactamase) - positive{{כ}}{{הערה|1=ESBL: extended spectrum beta-lactamase}}||15||32
|}

{{רווח קשיח}}
<div class="mw-content-ltr">

===Table 12c: Antimicrobial susceptibilities (%) of Pseudomonas aeruginosa isolated from urine cultures, 2001-2008===
</div>{{רווח קשיח}}
{| dir="ltr" border="1" cellpadding="4"
|
!≤48 hrs in hospital{{כ}}{{הערה|שם=הערה2|continues to be tested}}
!>48 hours in hospital{{הערה|שם=הערה2}}
|-
| colspan="3" |Penicillins
|-
|	[[Mezlocillin|Mezlocillin{{כ}}]]{{הערה|שם=הערה2}}||	77	||	73
|-
|	Tazocin	||	92	||	88
|-
| colspan="3" |	Cephalosporins
|-
|	Ceftazidime	||	92	||	89
|-
| Cefepime{{כ}}{{הערה|1=tested until 2006 }}||95||94
|-
| colspan="3" |Carbapenems
|-
|	Imipenem	||	94	||	91
|-
| [[Meropenem|Meropenem{{כ}}]]{{הערה|1=tested since 2006}}||	94	||	93
|-
| colspan="3" |Aminoglycosides
|-
|	Gentamicin	||	84	||	81
|-
|	Amikacin	||	94	||	93
|-
| colspan="3" |	Other
|-
|	Ciprofloxacin	||	73	||	69
|-
|	Colistin	||	100	||	100
|}

{{רווח קשיח}}
<div class="mw-content-ltr">
===Table 12d: Ten most frequently isolated organisms from urine cultures and risk of isolation in presence and absence of urinary catheter (1<sup>st</sup> trimesters, 1990-2000)===

</div>{{רווח קשיח}}
{|dir="ltr" border="1" cellpadding="4"
!rowspan="2"|No.
!rowspan="2"|Organism
!rowspan="2"|Isolates
(n=5272)
n (%)
!colspan="2"|Catheter
!rowspan="2"|RR{{כ}}{{הערה|1=	Relative risk of organism isolation in the presence versus absence of a catheter.}}
(95% CI)
!rowspan="2"|P
value
|-
!Absent
(n=3421) 
n (%)
!Present 
(n=1851)
n (%)
|-
|1||	Escherichia coli	||2540 (48)||	1822 (53)	||718 (39)||0.73 (0.69-0.78)||	<0.001
|-
|2	||	Klebsiella pneumoniae	||	574 (11)	||	340 (10)	||	234 (13)	||	1.28 (1.09-1.49)	||	0.002
|-
|	3	||	Pseudomonas aeruginosa	||	469 (9)	||	259 (8)	||	210 (11)	||	1.50 (1.27-1.79)	||	<0.001
|-
|	4	||	Enterococcus spp.	||	418 (8)	||	198 (6)	||	220 (12)	||	2.06 (1.72-2.47)	||	<0.001
|-
|	5	||	Proteus mirabilis	||	333 (6)	||	207 (6)	||	126 (7)	||	1.13 (0.91-1.40)	||	0.265
|-
|6||Staphylococcus coag (-)	||173 (3)||124 (4)||49 (3)||0.73 (0.53-1.01)||	0.06
|-
|	7	||	Enterobacter cloacae	||	129 (2)	||	75 (2)	||	54 (3)	||	1.34 (0.95-1.89)	||	0.099
|-
|	8	||	Acinetobacter baumanii	||	88 (2)	||	48 (1)	||	40 (2)	||	1.55 (1.02-2.34)	||	0.04
|-
|	9	||	Citrobacter freundii	||	72 (1)	||	46 (1)	||	26 (1)	||	1.05 (0.65-1.69)	||	0.846
|-
|10||Staphylococcus aureus||61 (1)||37 (1)||24 (1)||1.20 (0.72-2.00)||0.477
|-
|		||Total||4857 (92)||3156 (92)||1701 (92) ||		||	
|}

{{רווח קשיח}}
<div class="mw-content-ltr">

===Table 12e: Frequencies of isolation of selected Enterobacteriaceae, Pseudomonas and Enterococcus, according to source of patient (2001-2008). ===
</div>{{רווח קשיח}}
{|dir="ltr" border="1" cellpadding="4"
!Organism
!Total
n (%)
!Emergency Department
n (%)
!Hospital Departments
n (%)
!RR (95% CI){{כ}}{{הערה|1=Relative risk of organism isolation in emergency department versus inpatient departments.}}
!P value
|-
|	Enterobacteriaceae	||	3802 (72)||1586 (82)||2216 (66)||1.25 (1.21-1.29)	||	<0.001
|-
|Other organisms	||1470 (28)||	337 (18)||	1133 (34)||0.52 (0.47-0.58)||<0.001
|-
|	Escherichia coli	||	2508 (48)||	1219 (63)||	1289 (38)||1.65 (1.56-1.74)	||	<0.001
|-
|	Pseudomonas	||	469 (9)	||109 (6)	||	360 (11)	||0.53 (0.43-0.65)	||	<0.001
|-
|	Enterococcus spp.||418 (8)||63 (3)	||355 (11)||0.31 (0.24-0.40)||	<0.001
|-
|	All Isolates 	||5272	||	1923	||	3349		||	||
|}

== הערות שוליים ==

{{הערות שוליים}}

==ביבליוגרפיה==

<blockquote> 
<div style="text-align: left; direction: ltr">
#	Raveh D, Rudensky B, Huerta M, Aviv Y, Yinnon AM.  Use of time-trend analysis in the design of empirical antimicrobial treatment of urinary tract infection.  Eur J Clin Microbiol Infect Dis 2003; 22(3):158-64.
#	Raveh D, Rosenzweig I, Rudensky B, Yinnon AM. Prospective, case control study to determine risk factors for community-acquired urinary tract infection due to Pseudomonas aeruginosa or Enterococcus. Eur J Clin Microbiol Infect Dis 2006; 25: 331-334.
#	Raveh D, Rudensky B, Huerta M, Aviv Y, Yinnon AM.  Use of time-trend analysis in the design of empirical antimicrobial treatment of urinary tract infection.  Eur J Clin Microbiol Infect Dis 2003 Mar; 22(3):158-64.
</div>
</blockquote>

==ראו גם==

* לנושא הקודם: [[טבלאות רגישויות מבית החולים שערי צדק - תרביות ליחה]]
* לנושא הבא: [[אבחון, טיפול בידוד ומיגון כנגד מחוללים ביולוגיים מדבקים - Diagnosis, treatment and isolation for infectious biological agents]]

* [[שימוש מושכל באנטיביוטיקה|לתוכן העניינים של פנקס שימוש מושכל באנטיביוטיקה]]


[[קטגוריה: בריאות הציבור]]
[[קטגוריה: זיהומיות]]
[[קטגוריה: ילדים]]
[[קטגוריה: משפחה]]
[[קטגוריה: פנימית]]